UnitedHealth (NYSE: UNH) director receives 206 deferred stock units

Q: What insider transaction did UNITEDHEALTH GROUP INC (UNH) report for Michele J. Hooper?

UNITEDHEALTH GROUP INC reported that director Michele J. Hooper received 206 deferred stock units of common stock as regular quarterly compensation. The units were granted at $0.00 per share and represent a non-market, compensation-related acquisition rather than a purchase or sale.

Q: How many UNITEDHEALTH GROUP INC (UNH) shares does Michele J. Hooper hold after this grant?

Following the grant, director Michele J. Hooper holds 41,792 shares/units of UNITEDHEALTH GROUP INC common stock directly. This total includes the newly granted 206 deferred stock units and reflects her direct ownership position after the reported Form 4 transaction.

Q: What are the terms of the deferred stock units granted to the UNH director?

The deferred stock units granted to the UNITEDHEALTH GROUP INC director are immediately vested but must be retained until she completes service on the Board. They are issued as regular quarterly compensation for Board service and not acquired through an open-market transaction.

Q: Was there any cash paid for the 206 UNH shares reported in this Form 4?

No cash was paid for these shares. The Form 4 shows 206 shares of UNITEDHEALTH GROUP INC common stock acquired at a price of $0.00 per share , reflecting a grant or award of deferred stock units as part of director compensation.

Q: Does this UNITEDHEALTH GROUP INC (UNH) Form 4 indicate a buy or a grant by the director?

The Form 4 indicates a grant or award acquisition , not an open-market buy. Transaction code A and the description "Grant, award, or other acquisition" show that the 206 deferred stock units are compensation-related rather than a discretionary stock purchase.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

HOOPER MICHELE J reported acquisition or exercise transactions in this Form 4 filing.

UnitedHealth Group director Michele J. Hooper received a grant of 206 deferred stock units of common stock on April 1, 2026 as regular quarterly compensation for Board service. The units are immediately vested but must be held until her Board service ends, bringing her direct holdings to 41,792 shares/units. This is a routine compensation-related equity award rather than an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider HOOPER MICHELE J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	206	$0.00	--

Holdings After Transaction: Common Stock — 41,792 shares (Direct)

Footnotes (1)

[object Object]

Key Figures

Deferred stock units granted: 206 units Grant price per share: $0.00 per share Holdings after transaction: 41,792 shares/units

3 metrics

Deferred stock units granted 206 units Quarterly director compensation grant on April 1, 2026

Grant price per share $0.00 per share Compensation-related award, not open-market purchase

Holdings after transaction 41,792 shares/units Director Michele J. Hooper direct ownership after grant

Key Terms

deferred stock units, regular quarterly compensation, immediately vested, must be retained by the director until the director's completion of service on the Board, +1 more

5 terms

deferred stock units financial

"Represents deferred stock units that are granted as regular quarterly compensation"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

regular quarterly compensation financial

"granted as regular quarterly compensation for service as a director"

immediately vested financial

"Deferred stock units are immediately vested, but must be retained"

must be retained by the director until the director's completion of service on the Board financial

"must be retained by the director until the director's completion of service on the Board"

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

04/06/2026 - 05:04 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HOOPER MICHELE J

(Last)

(First)

(Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE

MINNESOTA

55344

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/01/2026		A		206⁽¹⁾	A	$0	41,792	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Michele J. Hooper	04/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did UNITEDHEALTH GROUP INC (UNH) report for Michele J. Hooper?

UNITEDHEALTH GROUP INC reported that director Michele J. Hooper received 206 deferred stock units of common stock as regular quarterly compensation. The units were granted at $0.00 per share and represent a non-market, compensation-related acquisition rather than a purchase or sale.

How many UNITEDHEALTH GROUP INC (UNH) shares does Michele J. Hooper hold after this grant?

Following the grant, director Michele J. Hooper holds 41,792 shares/units of UNITEDHEALTH GROUP INC common stock directly. This total includes the newly granted 206 deferred stock units and reflects her direct ownership position after the reported Form 4 transaction.

What are the terms of the deferred stock units granted to the UNH director?

The deferred stock units granted to the UNITEDHEALTH GROUP INC director are immediately vested but must be retained until she completes service on the Board. They are issued as regular quarterly compensation for Board service and not acquired through an open-market transaction.

Was there any cash paid for the 206 UNH shares reported in this Form 4?

No cash was paid for these shares. The Form 4 shows 206 shares of UNITEDHEALTH GROUP INC common stock acquired at a price of $0.00 per share, reflecting a grant or award of deferred stock units as part of director compensation.

Does this UNITEDHEALTH GROUP INC (UNH) Form 4 indicate a buy or a grant by the director?

The Form 4 indicates a grant or award acquisition, not an open-market buy. Transaction code A and the description "Grant, award, or other acquisition" show that the 206 deferred stock units are compensation-related rather than a discretionary stock purchase.